- Home
- OMDA vs AZTA Comparison
OMDA vs AZTA Comparison
Compare OMDA & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMDA
- AZTA
- Stock Information
- Founded
- OMDA 2011
- AZTA 1978
- Country
- OMDA United States
- AZTA United States
- Employees
- OMDA N/A
- AZTA N/A
- Industry
- OMDA Medical/Nursing Services
- AZTA Industrial Machinery/Components
- Sector
- OMDA Health Care
- AZTA Technology
- Exchange
- OMDA Nasdaq
- AZTA Nasdaq
- Market Cap
- OMDA 1.3B
- AZTA 1.4B
- IPO Year
- OMDA 2025
- AZTA 1995
- Fundamental
- Price
- OMDA $17.38
- AZTA $32.34
- Analyst Decision
- OMDA Strong Buy
- AZTA Buy
- Analyst Count
- OMDA 6
- AZTA 3
- Target Price
- OMDA $24.17
- AZTA $45.00
- AVG Volume (30 Days)
- OMDA 432.9K
- AZTA 565.7K
- Earning Date
- OMDA 08-07-2025
- AZTA 08-05-2025
- Dividend Yield
- OMDA N/A
- AZTA N/A
- EPS Growth
- OMDA N/A
- AZTA N/A
- EPS
- OMDA N/A
- AZTA N/A
- Revenue
- OMDA $189,668,000.00
- AZTA $669,171,000.00
- Revenue This Year
- OMDA $33.26
- AZTA N/A
- Revenue Next Year
- OMDA $20.16
- AZTA $4.74
- P/E Ratio
- OMDA N/A
- AZTA N/A
- Revenue Growth
- OMDA 38.29
- AZTA 8.56
- 52 Week Low
- OMDA $14.14
- AZTA $23.91
- 52 Week High
- OMDA $28.40
- AZTA $62.76
- Technical
- Relative Strength Index (RSI)
- OMDA N/A
- AZTA 49.73
- Support Level
- OMDA N/A
- AZTA $31.27
- Resistance Level
- OMDA N/A
- AZTA $34.87
- Average True Range (ATR)
- OMDA 0.00
- AZTA 1.52
- MACD
- OMDA 0.00
- AZTA -0.17
- Stochastic Oscillator
- OMDA 0.00
- AZTA 33.11
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.